Beta Bionics (BBNX) Treasury Shares (2025 - 2026)
Beta Bionics recorded quarterly Treasury Shares of $2.4 million in Q1 2026, up 219.73% quarter-over-quarter from $753885.0 in Q4 2025, and up 157.23% year-over-year from $937063.0 in Q1 2025.
Beta Bionics' Treasury Shares history runs 2 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 157.23% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 157.23% YoY), while the FY2025 annual figure was $753885.0, changed N/A from the prior year.
- Treasury Shares came in at $2.4 million for Q1 2026 at Beta Bionics, up from $753885.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.4 million in Q1 2026 to a low of $753885.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 256.42 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 263.29 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 325.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 900,000.00 |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 753,885.00 |
| Dec 31, 2025 | 753,885.00 |
| Sep 30, 2025 | 824,771.00 |
| Sep 30, 2025 | 824,771.00 |
| Jun 30, 2025 | 887,963.00 |
| Jun 30, 2025 | 887,963.00 |
| Mar 31, 2025 | 937,063.00 |
| Mar 31, 2025 | 937,063.00 |